You are on page 1of 3

Medication Information (IN/PCC/STY)

Gather information on all Scheduled and PRN medication that your patient will possibly get during your shift
Please highlight any unsafe dose or interactions among this clients medication list
Nursing Actions
Medications/
Drug Classification
IV Therapy

Humalog
1 unit/0.01mL
SOLN

Antidiabetic

Dose,
Route, and
Frequency

3 Units
SUBCUT
0100

Client Specific
Usage

Diabetes

4 Units
0500
6 Units
0900

Include: Specific administration requirements, lab


values, assessment data, side effects, patient teaching,
adverse effects, and/or any drug interactions among
this clients medication list.
WASTE IN BLACK CONTAINER
LOOK ALIKE/ SOUND ALIKE MED
If FBSB greater than 300 mg/dL with NO peripheral IV
present, do FSBS every 2 hours, urge indicated IV
doses and substitute SQ Humalog every 2 hours for IV
insulin. Resume previous orders when FSBS is 200
mg/dL
Administer 15 min before or immediately after meals
Subcutaneous only
Assess before administration, baseline CBC, blood
chemistries, urinalysis, renal function

7 Units
1300

Side effects: Localized redness, swelling, itching


Duloxetine HCl
60 mg CPEP

Antidepressant

60 mg
BY
MOUTH
0928
Daily

Depression

Caution with renal impairment, history of alcoholism,


chronic hepatic disease, and patients with suicidal
ideation or behavior
DO NOT OPEN CAPSULE OR CRUSH OR CHEW
Allow at least 14 days to elapse between use of MAOIs
and duloxetine
Assess appearance, behavior, speech pattern, level of
interest, sleep pattern
Side effects: Nausea, dry mouth, constipation,
insomnia

Estradiol
0.1mg TABS

Estrogen,
Antineoplastic

0.5 mg
BY
MOUTH
0928
Daily

Menopause

Alert: Increased risk of dementia when given to


women 65 yrs and older
Caution with renal insufficiency, diabetes,
endometriosis, asthma, hypocalcemia, hypertension
Side effects: Anorexia, nausea, swelling of breasts,
peripheral edema

Ezetimibe
10 mg TABS

Anticholesterol

10 mg
BY
MOUTH
0928
Daily

Cholesterol

LOOK ALIKE/ SOUND ALIKE MED


Caution with severe renal or mild hepatic impaitrment
Not recommended for those with moderate or sever
hepatic impairment

Obtain diet history, especially serum cholesterol


Side effects: Back pain, diarrhea, arthralgia, sinusitis,
abdominal pain
Gabapentin
800 mg TABS

Levothryoxine
Sodium
100 mcg TABS

Morphine
Sulfate ER
60 mg TBCR

Anticonvulsant,
Antineuralgic

Thyroid Hormone (T4)

Opiate analgesic

800 mg
BY
MOUTH
0928
BID

Seizure
prevention

100 mcg
BY
MOUTH
0929
Daily

Hypothyroidism

60 mg
BY
MOUTH
0929
Q12h

Moderate to
severe pain

Caution with severe renal impairment. Increased risk of


suicidal behavior
Review history of any seizures
Side effects: Fatigue, dizziness, drowsiness, ataxia
Alert: Ineffective, potentially toxic for weight
reduction
Obtain TSH, T3, T4, weight, and vital signs prior
Side effects: Reversible hair loss at start of therapy in
children
Rare: Dry skin, GI intolerance, rash, itches
DO NOT CRUSH
Extreme caution with COPD, hypoxia, hypercapnia,
preexisting respiratory depression, head injury
Caution with biliary tract disease, pancreatitis, CVD,
morbid obesity, adrenal insufficiency, elderly
Side effects: Sedation, decreased BP, orthostatic
hypotension, diaphoresis, flushing, constipation,
dizziness, drowsiness, nausea, vomiting
Watch for respiratory depression and vital signs!
Withhold medication if respiratory rate is less than 12

Enoxaparin
40 mg/0.4 mL

Anticoagulant

40 mg
SUBCUT
1000
Q24h

Prevent DVT

FOR CREATININE CLEARANCE GREATER THAN


OR EQUAL TO 30 mL/min
Obtain baseline CBC
Caution with patients with increased risk of
hemorrhage, platelet defects, renal impairment, elderly
DO NOT mix with other injections or infusions
DO NOT give IM, ONLY subcutaneous in the
abdomen

Metformin HCl
500 mg TABS

Antidiabetic

1000 mg
BY
MOUTH
BIDMW

Diabetes

Alert: Allow 1-2 weeks between dose titrations


Caution with heart failure, impaired hepatic function,
chronic alcohol intake, elderly
Assess glucose, Hgb A1c, CBC, renal function tests
Side effects: GI disturbances (diarrhea, nausea,
vomiting, abdominal bloating, flatulence, anorexia)

Have client report evidence of lactic acidosis if


discontinuing metformin

Continue on additional sheet, if needed.

You might also like